Zhi-Jie Ni

This inventor holds 17 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 4 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Novartis Vaccines & Diagnostics, Gmbh, Pharmacia & Upjohn Company, Chiron Corporation. Active years: 1998-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhi-Jie Ni. Retrieved from https://idiyas.com/inventor/zhi-jie-ni

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 1)

% Patents Active = 47.1

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 7.3

ph-index = 9

Forward Citations = 334(Granted Patents)

Location History:

Sunnyvale, CA (US) (1998 - 2002)
Fremont, CA (US) (2001 - 2010)
Emeryville, CA (US) (2010 - 2012)
Freemont, CA (US) (2013)

Company Filing History:

5 out of 245

Novartis Vaccines & Diagnostics, Gmbh

patents

3 out of 523

Pharmacia & Upjohn Company

Vicuron Pharmaceuticals Inc.

8. 1 out of 834,570

Other

patents

Years Active: 1998-2013

Loading Chart...

Areas of Expertise:

Pyrimidine Derivatives

PI-3 Kinase Inhibitors

Anticancer Agents

Thiosemicarbazones

Benzimidazole Quinolinones

Oxazolidinone Libraries

Glycogen Synthase Kinase

Semi-Synthetic Antibiotics

Urea Compounds

Combinatorial Libraries

Immunopotentiators

Guanidinobenzamides

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8563549 - Pyrimidine derivatives used as PI-3 kinase inhibitors (2013-10-22),

2. 8217035 - Pyrimidine derivatives used as PI-3-kinase inhibitors (2012-07-10),

3. 8173647 - PI 3-kinase inhibitors and methods of their use (2012-05-08),

4. 7855295 - Tetrahydrocarboline compounds as anticancer agents (2010-12-21),

5. 7671049 - Pyrrole based inhibitors of glycogen synthase kinase 3 (2010-03-02),

6. 7521062 - Thiosemicarbazones as anti-virals and immunopotentiators (2009-04-21),

7. 7470709 - Benzimidazole quinolinones and uses thereof (2008-12-30),

8. 7368422 - Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity (2008-05-06),

9. 7250443 - Pyrrole based inhibitors of glycogen synthase kinase 3 (2007-07-31),

10. 6852752 - Urea compounds, compositions and methods of use and preparation (2005-02-08),

11. 6797820 - Succinate compounds, compositions and methods of use and preparation (2004-09-28),

12. 6638927 - Guanidinobenzamides (2003-10-28),

13. 6562844 - Oxazolidinone combinatorial libraries, compositions and methods of preparation (2003-05-13),

14. 6531470 - Oxazolidinone combinatorial libraries, compositions and methods of preparation (2003-03-11),

15. 6368874 - Methods for hard-tagging an encoded synthetic library (2002-04-09),

Title: The Innovative Journey of Zhi-Jie Ni

Introduction: Zhi-Jie Ni, a talented inventor based in Fremont, CA, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Zhi-Jie Ni holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and creativity.

Career Highlights: With a background in engineering and a passion for problem-solving, Zhi-Jie Ni has led successful projects that have revolutionized industries and improved the quality of life for many.

Collaborations: Throughout his career, Zhi-Jie Ni has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life and create tangible solutions for complex challenges.

Conclusion: Zhi-Jie Ni's relentless pursuit of innovation and his commitment to pushing the boundaries of what is possible make him a true pioneer in the world of inventions. His work continues to inspire and shape the future of technology.

Profile summary based on public USPTO records.